The price-to-earnings ratio for Chemours Company (NYSE: CC) is 38.34x, which is above its average ratio. Moreover, the 36-month beta value for CC is 1.80. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 2 as “overweight,” 6 as “hold,” and 0 as “sell.”
The public float for CC is 148.33M and currently, short sellers hold a 4.82% of that float. On December 26, 2024, CC’s average trading volume was 1.70M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CC) stock’s latest price update
Chemours Company (NYSE: CC)’s stock price has plunge by 0.00relation to previous closing price of 17.54. Nevertheless, the company has seen a -3.68% plunge in its stock price over the last five trading sessions. businesswire.com reported 2024-12-13 that WILMINGTON, Del.–(BUSINESS WIRE)—- $CC–The Chemours Company Announces Completion of Euro denominated Term Loan Repricing.
CC’s Market Performance
Chemours Company (CC) has experienced a -3.68% fall in stock performance for the past week, with a -18.53% drop in the past month, and a -6.15% drop in the past quarter. The volatility ratio for the week is 4.04%, and the volatility levels for the past 30 days are at 4.06% for CC. The simple moving average for the last 20 days is -11.75% for CC stock, with a simple moving average of -21.88% for the last 200 days.
Analysts’ Opinion of CC
Many brokerage firms have already submitted their reports for CC stocks, with UBS repeating the rating for CC by listing it as a “Buy.” The predicted price for CC in the upcoming period, according to UBS is $30 based on the research report published on July 09, 2024 of the current year 2024.
Mizuho, on the other hand, stated in their research note that they expect to see CC reach a price target of $25. The rating they have provided for CC stocks is “Neutral” according to the report published on June 07th, 2024.
BMO Capital Markets gave a rating of “Outperform” to CC, setting the target price at $34 in the report published on April 09th of the current year.
CC Trading at -10.46% from the 50-Day Moving Average
After a stumble in the market that brought CC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -46.36% of loss for the given period.
Volatility was left at 4.06%, however, over the last 30 days, the volatility rate increased by 4.04%, as shares sank -20.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.12% lower at present.
During the last 5 trading sessions, CC fell by -3.68%, which changed the moving average for the period of 200-days by -32.85% in comparison to the 20-day moving average, which settled at $19.87. In addition, Chemours Company saw -44.39% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CC starting from Scarborough Alvenia, who sale 7,500 shares at the price of $20.64 back on Nov 07 ’24. After this action, Scarborough Alvenia now owns 16,645 shares of Chemours Company, valued at $154,771 using the latest closing price.
Scarborough Alvenia, the Officer of Chemours Company, proposed sale 7,500 shares at $20.00 during a trade that took place back on Nov 06 ’24, which means that Scarborough Alvenia is holding shares at $150,000 based on the most recent closing price.
Stock Fundamentals for CC
Current profitability levels for the company are sitting at:
- 0.07 for the present operating margin
- 0.2 for the gross margin
The net margin for Chemours Company stands at 0.01. The total capital return value is set at 0.07. Equity return is now at value 9.77, with 0.90 for asset returns.
Based on Chemours Company (CC), the company’s capital structure generated 0.86 points at debt to capital in total, while cash flow to debt ratio is standing at -0.07. The debt to equity ratio resting at 6.15. The interest coverage ratio of the stock is 1.44.
Currently, EBITDA for the company is 197.0 million with net debt to EBITDA at 6.47. When we switch over and look at the enterprise to sales, we see a ratio of 1.1. The receivables turnover for the company is 6.05for trailing twelve months and the total asset turnover is 0.77. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.73.
Conclusion
To wrap up, the performance of Chemours Company (CC) has been bad in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
